Received: 4 October 2019
Accepted: 6 February 2020
First Online: 6 March 2020
Ethics approval and consent to participate
: The VALIDATE-SWEDEHEART trial [CitationRef removed] was approved nationally by the ethics committee of Lund University, Sweden. In patients with STEMI, witnessed oral consent was obtained after angiography and before randomization. Within the following 24 h, after written information about the trial had been provided, the patients confirmed further participation by providing written informed consent. In patients with NSTEMI, written consent was obtained before angiography. In the telephone follow-up a week later, when searching for endpoints according to the main trial protocol, patients were asked to participate in this sub-study comprising four questions.
: Not applicable.
: The authors declare that they have no competing interests.